• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Ltk gene polymorphism and aberrant activation of autoreactive B cells

Research Project

Project/Area Number 14380385
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory animal science
Research InstitutionJUNTENDO UNIVERSITY

Principal Investigator

HIROSE Sachiko  Juntendo Univ. Sch. Med., Dept. Pathol., Associate Prof., 医学部, 助教授 (00127127)

Co-Investigator(Kenkyū-buntansha) 多田 昇弘  順天堂大学, 医学部, 講師 (50338315)
上野 博夫  国立がんセンター, 研究所・ウイルス部, 室長 (60332368)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥9,900,000 (Direct Cost: ¥9,900,000)
Fiscal Year 2003: ¥4,800,000 (Direct Cost: ¥4,800,000)
Fiscal Year 2002: ¥5,100,000 (Direct Cost: ¥5,100,000)
KeywordsLtk / Systemic lupus erythematosus / Gain-of-function polymorphism / B1 cell / SNP / Linkage study / PI3 kinase / Susceptible gene
Research Abstract

Systemic lupus erythematosus (SLE), a complex multigenic disease, is a typical antibody-mediated autoimmune disease characterized by production of autoantibodies against a variety of autoantigens and immune complex-type tissue inflammation, most prominently in the kidney. Evidence suggests that genetic factors predisposing to aberrant proliferation/maturation of self-reactive B cells initiate and propagate the disease. In SLE-prone New Zealand Black (NZB) mice and their F1 cross with New Zealand White (NZW) mice, B cell abnormalities can be ascribed mainly to self-reactive CD5^+ B1 cells. Our genome-wide scans to search for susceptibility genes for aberrant activation of B1 cells in these mice showed evidence that the gene, Ltk, encoding leukocyte tyrosine kinase (LTK), is a possible candidate. LTK is a receptor-type protein tyrosine kinase, belonging to the insulin receptor superfamily, and is mainly expressed in B lymphocyte precursors and neuronal tissues. Sequence and functional analyses of the gene revealed that NZB has a gain-of-function polymorphism in the LTK kinase domain near YXXM, a binding motif of the p85 subunit of phosphatidylinositol 3-kinase (P13K). SLE patients also had this type of Ltk polymorphism with a significantly higher frequency compared to the healthy controls. Our findings suggest that these polymorphic LTKs cause up-regulation of the PI3K pathway and possibly form one genetic aspect for susceptibility to abnormal proliferation of self-reactive B cells in SLE.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (24 results)

All Other

All Publications (24 results)

  • [Publications] A, Miyamoto, et al.: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ"Nature. 416. 865-869 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y.Miura-Shimura, et al.: "C1q regulatory region polymorphism down-regulating murine C1q protein levels with linkage to lupus nephritis."J.Immunol.. 169. 1334-1339 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Y.Xie, et al.: "Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses."J.Immunol.. 169. 4340-4346 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] S.Matsuoka, et al.: "A monoclonal antibody to the α2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model"J.Exp.Med.. 198. 497-503 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] N.Li, et al.: "Gain-of-function polymorphism in mouse and human Ltk : implications for the pathogenesis of systemic lupus erythematosus."Hum.Mol.Genet.. 13. 171-179 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] X.Wen, et al.: "Transgene-mediated over-expression of interleukin-5 suppresses autoimmune disease, but increases the risk of B cell chronic lymphocytic leukemia. Blood"J.Immunol.. (submitted for publication.)(In press). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miyamoto A, Nakayama K, Hirose S, Jiang Y, Abe M, Tsukiyama T, Nagahama H., Ohno S., Hatakeyama S, Nakayama K: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ."Nature. 416. 865-869 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Miura-Shimura Y, Nakamura K, Ohtsuji M, Tomita H, Jiang Y, Abe M, Zhang D, Hamano Y, Tsuda H, Hashimoto H, Nishimura H, Taki S, Shirai T, Hirose S: "C1q regulatory region polymorphism down-regulating murine C1q protein levels with linkage to lupus nephritis"J Immunol. 169. 1334-1339 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Xie Y, Nakamura K, Abe M, Li N, Wen X-S, Jiang Y, Zhang D, Tsurui H, Matsuoka S, Hamano Y, Fujii H, Ono M, Takai T, Shimokawa T, Ra C, Shirai T, Hirose S: "Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses."J Immunol. 169. 4340-4346 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Matsuoka S, Tsurui H, Abe M, Terashima K, Nakamura K, Hamano Y, Ohtsuji M, Honma N, Serizawa I, Ishii Y, Takiguchi M. Hirose S, Shirai T.: "A monoclonal antibody to the α2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model."J Exp Med. 198. 497-503 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Li N, Nakamura K, Jiang Y, Tsurui H, Matsuoka S, Abe M, Ohtsuji M, Nishimura H, Kato K, Kawai T, Atsumi T, Koike T, Shirai T, Ueno H, Hirose S: "Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus."Hum Mol Genet. 13. 171-179 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Wen X, Zhang D, Abe M, hang Y, Nakamura K, Hamano Y, Kikuchi Y, Takatsu K, Shirai T, Hirose S: "Transgene-mediated over-expression of interleukin-5 suppresses autoimmune disease, but increases the risk of B cell chronic lymphocytic leukemia."J Immunol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] K.Nakamura et al.: "Genetic dissection of anxiety in autoimmune disease."Hum.Mol.Genet.. 12. 1079-1086 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] S.Fujimura, et al.: "Spontaneous increase of plasma-like cells with high GAMP expression in the extrafollicular region of lymphoid organs of autoimmune-prone mice."Autoimmunity. 20. 291-301 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] S.Matsuoka, et al.: "A monoclonal antibody to the α2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model."J.Exp.Med.. 198. 497-503 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] H.Iwai, et al.: "Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis."J.Immunol.. 171. 2848-2854 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] N.Li, et al.: "Gain-of-function polymorphism in mouse and human Ltk : implications for the pathogenesis of systemic lupus erythematosus."Hum.Mol.Genet.. 13. 171-179 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] X.Wen, et al.: "Transgene-mediated over-expression of interleukin-5 suppresses autoimmune disease, but increase the risk of B cell chronic lymphocytic leukemia. Blood, submitted for publication."J.Immunol.. (In press). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Miyamoto A, et al.: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ"Nature. 416. 865-869 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Miura-Shimura Y, et al.: "Clq regulatory region polymorphism down-regulating murine Clq protein levels with linkage to lupus nephritis"J.Immunol.. 169. 1334-1339 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Xie Y, et al.: "Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses"J.Immunol.. 169. 4340-4346 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Iwai H, et al.: "Amelioration of collagen-induced arthritis by brokade of inducible costimulator-b7 homologous protein costimulation"J.Immunol.. 169. 4332-4339 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Shirai T, et al.: "Genome screening for susceptibility loci in systemic lupus erythematosus"Am.J.Pharmacogenomics. 2. 1-12 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Hirose S. et al.: "Genetic basis of systemic lupus erythematosus"Drugs of Today. 38. 167-184 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi